Erythropoietin to treat anaemia in patients with head and neck cancer.

Lancet

Volumn 363, Issue 9402, 2004, Pages

  Haddad, Robert ^a   Posner, Marshall ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ANEMIA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEAD AND NECK TUMOR; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NOTE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; STANDARD;

ANEMIA; ANTINEOPLASTIC PROTOCOLS; COMBINED MODALITY THERAPY; ERYTHROPOIETIN; HEAD AND NECK NEOPLASMS; HUMANS; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

MLCS; MLOWN;

EID: 1442332088     PISSN: None     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/s0140-6736(03)15184-7     Document Type: Note

References (0)